A new study led by the National Institute on Aging (NIA) suggests that older adults living with obesity and metabolic issues can boost their brain health by following a healthy diet.

New results from the SELECT trial show that semaglutide 2.4 mg significantly reduces all-cause mortality in patients with obesity and cardiovascular disease, including deaths related to COVID-19.

Weight-loss medications may be a powerful tool in tackling obesity, but they are not the ultimate solution to the crisis, according to Professor Stephen Powis, NHS England's Medical Director.

Proposals to provide weight loss injections to unemployed people living with obesity could have a significant impact on both the economy and public health, according to Prime Minister Sir Keir Starmer.

A new population-based cohort study from Sweden has revealed significant links between overweight and obesity and adverse pregnancy outcomes, highlighting differences between Swedish-born and migrant women.

A new study presented at the 2024 Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS) reveals that bariatric surgery is far more effective at maintaining weight loss compared to lifestyle changes and glucagon-like peptide-1 (GLP-1) medications.

Obesity rates in England are showing signs of stabilising, according to new figures released by the NHS. The data reveals that the number of children who are overweight has dropped to its lowest level since 2000, and obesity rates among adults have remained stable over the last five years.

A new study from the University of Copenhagen has identified lipid biomarkers in children and teenagers living with obesity that signal an increased risk of developing serious health issues.

A new international study has provided valuable insights, exploring the prevalence of obesity among adults living with and without type 1 diabetes across three different global regions.

A new study presented at the 2024 Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS) reveals that bariatric surgery is far more effective at maintaining weight loss compared to lifestyle changes and glucagon-like peptide-1 (GLP-1) medications.

Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.

A significant increase in children walking and cycling to school has been credited for a notable reduction in childhood obesity rates in Guernsey.

A recent trial, published in The New England Journal of Medicine and presented at the European Association for the Study of Diabetes Obesity (EASD), demonstrated that liraglutide effectively lowered body mass index (BMI) in children, but the occurrence of side effects indicates a need for further research.

On October 16, 2024, the Obesity Health Alliance (OHA) will launch a new position statement calling for significant policy changes to improve obesity management services across England.

Following the incredible success of the inaugural event held earlier this year in Birmingham, the 2025 conference will take place in London, offering excellent transport links and accessibility for UK registered healthcare professionals.

Liverpool City Council is exploring a proposal to ban junk food advertisements on its billboards and properties in an effort to address the city's growing obesity problem.

Researchers found that higher levels of interleukin-6 were associated with increased risk of obesity-related cancers in people who have recently been diagnosed with type 2 diabetes.

Individuals who received a once-a-day oral weight loss drug lost up to 13 per cent of their body weight over three months, according to research presented at EASD 2024.

Semaglutide, a drug commonly prescribed under the brand names Ozempic and Wegovy for treating Type 2 diabetes and obesity, may also have the potential to slow down the ageing process, according to new research.